代謝症候群一年發生率與消失率的危險因子與準則變化之探討

以作者查詢圖書館館藏

、以作者查詢臺灣博碩士

、以作者查詢全國書目

、勘誤回報

、線上人數：33

、訪客IP：3.139.105.18

姓名

吳翔業(Hsiang-yeh Wu) 查詢紙本館藏

畢業系所

資訊工程學系在職專班

論文名稱

代謝症候群一年發生率與消失率的危險因子與準則變化之探討
(The Risk Factors and Components Change in Metabolic Syndrome One Year Incidence and Recovery)

相關論文

★ 應用嵌入式系統於呼吸肌肉群訓練儀之系統開發	★ 勃起障礙與缺血性心臟病的雙向研究: 以台灣全人口基礎的世代研究
★ 基質輔助雷射脫附飛行時間式串聯質譜儀微生物抗藥性資料視覺化工具	★ 使用穿戴式裝置分析心律變異及偵測心律不整之應用程式
★ 建立一個自動化分析系統用來分析任何兩種疾病之間的關聯性透過世代研究設計以及使用承保抽樣歸人檔	★ 青光眼病患併發糖尿病,使用Metformin及Sulfonylurea治療得到中風之風險:以台灣人口為基礎的觀察性研究
★ 利用組成識別和序列及空間特性構成之預測系統來針對蛋白質交互作用上的特殊區段點位進行分析及預測辨識	★ 新聞語意特徵擷取流程設計與股價變化關聯性分析
★ 藥物與疾病關聯性自動化分析平台設計與實作	★ 建立財務報告自動分析系統進行股價預測
★ 建立一個分析疾病與癌症關聯性的自動化系統	★ 基於慣性感測器虛擬鍵盤之設計與實作
★ 一個醫療照護監測系統之實作	★ 應用手機開發手握球握力及相關資料之量測
★ 利用關聯分析全面性的搜索癌症關聯疾病	★ 全面性尋找類風濕性關節炎之關聯疾病

檔案

[Endnote RIS 格式]

[Bibtex 格式]

[相關文章]

[文章引用]

[完整記錄]

[館藏目錄]

[檢視]

[下載]

本電子論文使用權限為同意立即開放。
已達開放權限電子全文僅授權使用者為學術研究之目的，進行個人非營利性質之檢索、閱讀、列印。
請遵守中華民國著作權法之相關規定，切勿任意重製、散佈、改作、轉貼、播送，以免觸法。

摘要(中)

近年來，因為飲食文化與生活型態的改變，腦心血管疾病、高血壓、糖尿病等慢
性疾病已慢慢取代傳染性疾病而危害著國人的健康。在過去，一般認為只要血
壓、血脂、血糖只要還在正常範圍都是健康的，但是臨床上，這些病變因子若有
多項趨近異常範圍，慢性疾病還是會慢慢形成。所以在預防醫學的角度，也將視
野往前推進至病前的症狀 – 代謝症候群。
代謝症候群發生率的研究，很少觸及BMI或體重變化以外其他相關因子的變化對
其發生率的影響，也很少研究討論代謝症候群在研究樣本追蹤一段時間後消失的
原因，所以我們收集了2003到2009 壢新醫院於社區健康篩檢計畫所收集社區民
眾的健康檢查資料，利用邏輯回歸的統計方法，來探討其危險因子、判定準則的
改變量與高血脂用藥，對代謝症候群形成及消失的影響。

摘要(英)

In recent years, because of the diet culture and the lifestyle change, cardiacerebrovascular
disease, hypertension, diabetes and other chronic diseases have
replaced infectious diseases and slowly endanger people’’s health. In past years, we
generally believed that blood pressure, blood lipids and blood glucose still in the
normal range are healthy. However, in clinic, if many risk factors are closer to
abnormal range, the chronic diseases will be occurred. Therefore, in the perspective of
preventive medicine, we more care about the symptoms before disease - Metabolic
Syndrome.
Some metabolic syndrome (MetS) research focused on the association of the
variation of components with the incidence of MetS, except the BMI and weight
change, and few has been reported on recovery of MetS. In this study, we collected
the community outreaching project data during 2003 to 2009 in Li-shin hospital.
And we used the logistic regression to analyse the relationship of the risk factors and
the change of components in one year recovery and incidence of MetS.

關鍵字(中)

★ 發生率
★ 代謝症候群
★ 消失率

關鍵字(英)

★ Incednece
★ Metabolic syndrome
★ Recovery

論文目次

摘要............................................................................................................................... I
ABSTRACT ................................................................................................................. II
致謝............................................................................................................................. III
TABLE OF CONTENTS .......................................................................................... IV
LIST OF TABLE ....................................................................................................... VI
LIST OF FIGTURE ................................................................................................. VII
CHAPTER 1 INTRODUCTION ............................................................................. 1
1.1 BACKGROUND ....................................................................................................... 1
1.2MOTIVATION .......................................................................................................... 2
1.3 GOAL ..................................................................................................................... 2
CHAPTER 2 RELATED WORKS .......................................................................... 3
2.1METABOLIC SYNDROME ........................................................................................ 3
2.2 LOGISTIC REGRESSION .......................................................................................... 6
CHAPTER 3 METHODS AND MATERIALS ...................................................... 7
3.1 SYSTEM FLOW ....................................................................................................... 7
3.2 STUDY POPULATION .............................................................................................. 8
3.3ANTHROPOMETRIC MEASUREMENTS AND BLOOD PRESSURE MEASURES .............. 9
3.4 BIOCHEMICAL PARAMETERS ................................................................................ 10
3.5MAJOR LIFESTYLE VARIABLES ............................................................................ 10
3.6 DEFINITIONS OF METABOLIC SYNDROME ............................................................ 10
3.7 STATISTICAL ANALYSIS ........................................................................................ 11
CHAPTER 4 RESULTS ......................................................................................... 14
4.1 STATISTICAL RESULT AT BASELINE ...................................................................... 14
4.2 ONE YEAR INCIDENCE AND RECOVERY ............................................................... 16
4.3 UNIVARIATE AND MULTIVARIATE LOGISTIC REGRESSION ANALYSIS ................... 21
4.3.1 Metabolic Abnormalities ............................................................................. 21
4.3.2 Change of Risk Factors and Components ................................................... 24
V
4.3.3 Medication Use ............................................................................................ 30
CHAPTER 5 DISCUSSION .................................................................................. 34
CHAPTER 6 CONCLUSION AND FUTURE WORKS ..................................... 38
REFERENCES ........................................................................................................... 39

參考文獻

1. Reaven, G.M., Role of insulin resistance in human disease (syndrome X): an
expanded definition. Annu Rev Med, 1993. 44: p. 121-31.
2. Sattar, N., et al., Metabolic syndrome with and without C-reactive protein as a
predictor of coronary heart disease and diabetes in the West of Scotland
Coronary Prevention Study. Circulation, 2003. 108(4): p. 414-9.
3. Huang, P.L., A comprehensive definition for metabolic syndrome. Dis Model
Mech, 2009. 2(5-6): p. 231-7.
4. Opie, L.H., Metabolic syndrome. Circulation, 2007. 115(3): p. e32-5.
5. Lakka, H.M., et al., The metabolic syndrome and total and cardiovascular
disease mortality in middle-aged men. JAMA, 2002. 288(21): p. 2709-16.
6. Ford, E.S., W.H. Giles, and W.H. Dietz, Prevalence of the metabolic
syndrome among US adults: findings from the third National Health and
Nutrition Examination Survey. JAMA, 2002. 287(3): p. 356-9.
7. Park, Y.W., et al., The metabolic syndrome: prevalence and associated risk
factor findings in the US population from the Third National Health and
Nutrition Examination Survey, 1988-1994. Arch Intern Med, 2003. 163(4): p.
427-36.
8. Ford, E.S. and W.H. Giles, A comparison of the prevalence of the metabolic
syndrome using two proposed definitions. Diabetes Care, 2003. 26(3): p.
575-81.
9. Assmann, G., et al., Harmonizing the definition of the metabolic syndrome:
comparison of the criteria of the Adult Treatment Panel III and the
International Diabetes Federation in United States American and European
populations. Am J Cardiol, 2007. 99(4): p. 541-8.
10. Alberti, K.G. and P.Z. Zimmet, Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998.
15(7): p. 539-53.
11. Third Report of the National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III) final report. Circulation, 2002. 106(25): p.
3143-421.
12. Zimmet, P., et al., The metabolic syndrome: a global public health problem
and a new definition. J Atheroscler Thromb, 2005. 12(6): p. 295-300.
13. Grundy, S.M., et al., Diagnosis and management of the metabolic syndrome:
40
an American Heart Association/National Heart, Lung, and Blood Institute
scientific statement: Executive Summary. Crit Pathw Cardiol, 2005. 4(4): p.
198-203.
14. Alberti, K.G., et al., Harmonizing the metabolic syndrome: a joint interim
statement of the International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung, and Blood Institute;
American Heart Association; World Heart Federation; International
Atherosclerosis Society; and International Association for the Study of Obesity.
Circulation, 2009. 120(16): p. 1640-5.
15. Balkau, B., et al., Frequency of the WHO metabolic syndrome in European
cohorts, and an alternative definition of an insulin resistance syndrome.
Diabetes Metab, 2002. 28(5): p. 364-76.
16. Anand, S.S., et al., Relationship of metabolic syndrome and fibrinolytic
dysfunction to cardiovascular disease. Circulation, 2003. 108(4): p. 420-5.
17. Gupta, R., et al., Prevalence of metabolic syndrome in an Indian urban
population. Int J Cardiol, 2004. 97(2): p. 257-61.
18. Kozan, O., et al., Prevalence of the metabolic syndrome among Turkish adults.
Eur J Clin Nutr, 2007. 61(4): p. 548-53.
19. Zabetian, A., F. Hadaegh, and F. Azizi, Prevalence of metabolic syndrome in
Iranian adult population, concordance between the IDF with the ATPIII and
the WHO definitions. Diabetes Res Clin Pract, 2007. 77(2): p. 251-7.
20. Park, H.S., et al., The metabolic syndrome and associated lifestyle factors
among South Korean adults. Int J Epidemiol, 2004. 33(2): p. 328-36.
21. Tan, C.E., et al., Can we apply the National Cholesterol Education Program
Adult Treatment Panel definition of the metabolic syndrome to Asians?
Diabetes Care, 2004. 27(5): p. 1182-6.
22. Gu, D., et al., Prevalence of the metabolic syndrome and overweight among
adults in China. Lancet, 2005. 365(9468): p. 1398-405.
23. Feng, Y., et al., Prevalence of metabolic syndrome and its relation to body
composition in a Chinese rural population. Obesity (Silver Spring), 2006.
14(11): p. 2089-98.
24. Morales, D.D., et al., Metabolic syndrome in the Philippine general
population: prevalence and risk for atherosclerotic cardiovascular disease
and diabetes mellitus. Diab Vasc Dis Res, 2008. 5(1): p. 36-43.
25. Wang, W., et al., Epidemiological investigation of metabolic syndrome and
analysis of relevant factors in north-eastern China. J Int Med Res, 2010. 38(1):
p. 150-9.
26. Ko, G.T., et al., High prevalence of metabolic syndrome in Hong Kong
41
Chinese--comparison of three diagnostic criteria. Diabetes Res Clin Pract,
2005. 69(2): p. 160-8.
27. Pan, W.H., W.T. Yeh, and L.C. Weng, Epidemiology of metabolic syndrome
in Asia. Asia Pac J Clin Nutr, 2008. 17 Suppl 1: p. 37-42.
28. Chuang, S.Y., C.H. Chen, and P. Chou, Prevalence of metabolic syndrome in
a large health check-up population in Taiwan. J Chin Med Assoc, 2004.
67(12): p. 611-20.
29. Chen, H.J. and W.H. Pan, Probable blind spot in the International Diabetes
Federation definition of metabolic syndrome. Obesity (Silver Spring), 2007.
15(5): p. 1096-100.
30. Chen, H.J., et al., Influence of metabolic syndrome and general obesity on the
risk of ischemic stroke. Stroke, 2006. 37(4): p. 1060-4.
31. Zabetian, A., et al., Weight change and incident metabolic syndrome in
Iranian men and women; a 3 year follow-up study. BMC Public Health, 2009.
9: p. 138.
32. Kim, B.J., et al., Association of smoking status, weight change, and incident
metabolic syndrome in men: a 3-year follow-up study. Diabetes Care, 2009.
32(7): p. 1314-6.
33. Sheu, W.H., et al., Predictors of incident diabetes, metabolic syndrome in
middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes
Res Clin Pract, 2006. 74(2): p. 162-8.
34. Yang, F.Y., M.L. Wahlqvist, and M.S. Lee, Body mass index (BMI) as a
major factor in the incidence of the metabolic syndrome and its constituents in
unaffected Taiwanese from 1998 to 2002. Asia Pac J Clin Nutr, 2008. 17(2): p.
339-51.
35. Chobanian, A.V., et al., The Seventh Report of the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:
the JNC 7 report. JAMA, 2003. 289(19): p. 2560-72.
36. Heng, D., et al., Modification of the NCEP ATP III definitions of the metabolic
syndrome for use in Asians identifies individuals at risk of ischemic heart
disease. Atherosclerosis, 2006. 186(2): p. 367-73.
37. Sjostrom, L., et al., Lifestyle, diabetes, and cardiovascular risk factors 10
years after bariatric surgery. N Engl J Med, 2004. 351(26): p. 2683-93.
38. Esposito, K., et al., Effect of weight loss and lifestyle changes on vascular
inflammatory markers in obese women: a randomized trial. JAMA, 2003.
289(14): p. 1799-804.
39. Moore, L.L., et al., Can sustained weight loss in overweight individuals
reduce the risk of diabetes mellitus? Epidemiology, 2000. 11(3): p. 269-73.
42
40. Tuomilehto, J., et al., Prevention of type 2 diabetes mellitus by changes in
lifestyle among subjects with impaired glucose tolerance. N Engl J Med, 2001.
344(18): p. 1343-50.

指導教授

洪炯宗(Jorng-tzong Horng)

審核日期

2011-8-28

推文